Multiple Sclerosis
Conference Coverage
Teriflunomide delays MS symptoms in radiologically isolated syndrome
The data support the theory that treatment should begin early in patients with a high likelihood of developing symptomatic MS on the basis of...
Conference Coverage
High-dose vitamin D and MS relapse: New phase 3 data
The study found no benefit, but was the exclusion criteria to blame?
Conference Coverage
Machine learning can predict primary progressive MS progression
The model, which is clinically viable even as it is still evolving, predicts disability progression with an accuracy of approximately 70%.
Conference Coverage
Mediterranean diet improves cognition in MS
Dietary modification showed stronger associations between diet and cognition with progressive disease as opposed to relapsing disease.
Latest News
Risk for MS in children often missed
Children, unlike adults, may not need to meet the current clinical standard criteria to be considered at risk for MS.
Commentary
Can particles in dairy and beef cause cancer and MS?
Researchers found single-stranded DNA rings that originated in viruses, which they named bovine meat and milk factors, in the intestines of...
Conference Coverage
Physical activity is a growing priority for patients with MS
Recent research suggests that exercise may benefit patients with MS.
Conference Coverage
New digital tools hold promise for patients with MS
High-tech tools currently in development can detect not only motor and visual dysfunction but also cognitive dysfunction.
Conference Coverage
MS looks homogeneous
An analysis of clinical factors and treatment responses calls for personal rather than precision medicine.
Conference Coverage
Portable MRI has potential for MS
A blinded study showed good agreement with high-field MRI for some applications, but more development is needed.
Conference Coverage
A better MS measure?
A ‘digital carpet’ may provide more granular information about functional decline in patients with MS.